[go: up one dir, main page]

KR860003269A - 항균 조성물 및 그 유효성분의 제조방법 - Google Patents

항균 조성물 및 그 유효성분의 제조방법 Download PDF

Info

Publication number
KR860003269A
KR860003269A KR1019850007829A KR850007829A KR860003269A KR 860003269 A KR860003269 A KR 860003269A KR 1019850007829 A KR1019850007829 A KR 1019850007829A KR 850007829 A KR850007829 A KR 850007829A KR 860003269 A KR860003269 A KR 860003269A
Authority
KR
South Korea
Prior art keywords
residues
same
4g1cnacβ1
represent
hydrogen atom
Prior art date
Application number
KR1019850007829A
Other languages
English (en)
Other versions
KR910008798B1 (ko
Inventor
네세르 쟝-리샤르
Original Assignee
앙드레제이 레드지옹
소시에 떼 데 프로듀이 네슬레 소시에 떼 아노님
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 앙드레제이 레드지옹, 소시에 떼 데 프로듀이 네슬레 소시에 떼 아노님 filed Critical 앙드레제이 레드지옹
Publication of KR860003269A publication Critical patent/KR860003269A/ko
Application granted granted Critical
Publication of KR910008798B1 publication Critical patent/KR910008798B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/14—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
    • A01N43/16—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pest Control & Pesticides (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)

Abstract

내용 없음

Description

항균 조성물 및 그 유효성분의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (8)

  1. 하기 일반식(Ⅰ)의 당펩티드 및/또는 올리고 당류를 유효성분으로 함유함을 특징으로 하는, Ⅰ형 섭모(fimbriae)를 갖는 병원성균에 대한 항균 조성물.
    식중 R1은 수소원자, 4G1cNAcβ1→ASN 잔기 또는 4G1cNACβ1→잔기(R' 및 R"는 같거나, 서로 다르며 아미노산잔기 또는 폴리펩티드 잔기를 나타낸다.)이고; R2, R3및 R4는 같거나 서로 다르며 수소원자, 만노스잔기 또는 올리고만노시드 사슬을 나타낸다.
  2. 제1항에 있어서, R1이 4G1cNAβ1→ASN잔기 또는 4G1cNAcβ1→잔기(R' 및 R″는 같거나 서로 다르며 아미노산잔기 또는 폴리펩티드 사슬을 나타낸다)이고; R3및 R4가 수소원자를 나타내고 R2가 수소원자 또는 만노스 잔기인 일반식(Ⅰ)의 화합물을 유효 성분으로 함유함을 특징으로 하는 조성물.
  3. 제1항에 있어서, R1,R3및 R4가 수소원자이고, R2가 수소원자 또는 만노스 잔기인 일반식(Ⅰ)의 화합물을 유효성분으로 함유함을 특징으로 하는 조성물.
  4. 제1항에 있어서, 바람직하게는 공유 결합에 의해 고분자 지지체에 결합된 일반식(Ⅰ) 〔식중 R1은 4G1cNAcβ1→ASN 잔기 또는 4G1cNAcβ1→잔기(R',R″는 상지 제1항의 정의와 같다.)이고 R1,R2,R3및 R4가 상기 제1항의 정의와 동일하다.〕의 당펩티드를 함유함을 특징으로 하는 조성물.
  5. 제1항 내지 3항중 어느 하나에 있어서, 식품의 형태, 바람직하게는 분유의 형태인 조성물.
  6. 단백질 분해효소를 이용하여 식물성 유래당단백질을 분해하고, 생성된 당텝티드를 엔도-β--아세틸글루코사미니다아제 H를 이용하여 올리고당류로 전환시키고, 당펩티드 또는 소득한 올리고 당류를 두만노스 잔기 사이의 α1→2결합을 우선적으로 절단하는 엑소-α-만노시다아제를 이용한 조절분해시킴을 특징으로 하는 일반식(Ⅰ)에 해당하는 당펩티드의 제조방법.
    식중 R1은 수소원자, 4G1cNAcβ1→ASN 잔기 또는 4G1cNAcβ1→잔기(R' 및 R″는 같거나 서로 다르며 아미노산 잔기 또는 폴리펩티드 사슬을 나타낸다)를 나타내고; R2,R3및 R4는 같거나 서로 다르며 수소원자, 만노스 잔기 또는 올리고만노시드 사슬을 나타낸다.
  7. 제6항에 있어서, 원료인 당펩티드가 탈지 식물성분말에서 분리한 것이고, 바람직하게는 콩(soya-bean) 당단백질 7 S 또는 콩(bean) 당단백질 Ⅱ가 풍부한 분리물의 형태임을 특징으로 하는 방법.
  8. 활성 고분자 지지체를 당펩티드 용액과 반응시킴을 특징으로 하는 공유결합에 의해 고분자 지지체에 결합된 하기 일반식(Ⅰ)의 당펩티드를 함유하는 조성물의 제조방법.
    식중 R1은 AG1NAcβ1→ASN 잔기 또는 4G1cNAcβ1→잔기(R' 및 R″는 같거나 서로 다르며 아미노산잔기 또는 폴리펩티드 사슬을 나타낸다.)이고, R2,R3및 R4는 같거나 서로 다르며 수소원자, 만노스 잔기 또는 올리고만노시드 사슬을 나타낸다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019850007829A 1984-10-26 1985-10-23 항균 조성물과 그 유효성분의 제조방법 KR910008798B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH5136/84-6 1984-10-26
CH5136/84A CH660557A5 (fr) 1984-10-26 1984-10-26 Composition anti-bacterienne et procede de preparation de ses constituants actifs.

Publications (2)

Publication Number Publication Date
KR860003269A true KR860003269A (ko) 1986-05-21
KR910008798B1 KR910008798B1 (ko) 1991-10-21

Family

ID=4288552

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850007829A KR910008798B1 (ko) 1984-10-26 1985-10-23 항균 조성물과 그 유효성분의 제조방법

Country Status (15)

Country Link
US (1) US4939123A (ko)
EP (1) EP0179324B1 (ko)
JP (1) JP2566913B2 (ko)
KR (1) KR910008798B1 (ko)
AT (1) ATE68501T1 (ko)
AU (1) AU577411B2 (ko)
CA (1) CA1280987C (ko)
CH (1) CH660557A5 (ko)
DE (1) DE3584414D1 (ko)
ES (2) ES8800360A1 (ko)
FI (1) FI86081C (ko)
IL (1) IL76628A (ko)
NO (1) NO164719C (ko)
PT (1) PT81372B (ko)
ZA (1) ZA857842B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2605185B1 (fr) * 1986-10-17 1993-08-20 Meiji Seika Kaisha Procede de culture des plantes
DE68910212T2 (de) * 1988-07-12 1994-03-03 Aquaspersions Ltd Bekämpfung unerwünschter Schädlinge.
US5041236A (en) * 1989-10-27 1991-08-20 The Procter & Gamble Company Antimicrobial methods and compositions employing certain lysozymes and endoglycosidases
EP0425016B1 (en) * 1989-10-27 1995-12-20 The Procter & Gamble Company Antimicrobial method and formulation employing type II endoglycosidase and antimicrobial agent
US5238843A (en) * 1989-10-27 1993-08-24 Genencor International, Inc. Method for cleaning a surface on which is bound a glycoside-containing substance
US5258304A (en) * 1989-10-27 1993-11-02 Genencor International, Inc. Method of removing microorganisms from surfaces with Type II endoglycosidase
US5141925A (en) * 1990-04-23 1992-08-25 Trustees Of Tufts College Vivo methods for treating coccidiosis
US5718909A (en) * 1991-02-18 1998-02-17 Medscand Ab Sheet containing carbohydrate derivative for removal of E. coli
US5500206A (en) * 1994-04-29 1996-03-19 The Procter & Gamble Company Oral compositions comprising actinomyces viscosus fimbriae
JP3576720B2 (ja) 1996-10-15 2004-10-13 株式会社東海理化電機製作所 ダイアル操作装置
JP3061616B1 (ja) * 1999-04-09 2000-07-10 株式会社セラリカ野田 低カロリ―調製ロ―ヤルゼリ―
FR2802536B1 (fr) * 1999-11-23 2003-06-13 Chru Lille Oligomannosides de synthese, leur preparation et leur utilisation a la detection d'anticorps et a la prevention d'infections
ITMI20030391A1 (it) * 2003-03-04 2004-09-05 S I I T S R L Servizio Internaz Ionale Imballa Formulazioni anticarie a base di faseolamina.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH14773A (en) * 1976-01-01 1981-12-09 Kureha Chemical Ind Co Ltd Protein-bound polysaccharides
JPS5576818A (en) * 1978-12-06 1980-06-10 Hitoshi Ito Agent for improving hepatic function
AU6770981A (en) * 1980-01-28 1981-08-17 Svensson, S. E. Isolation of carbohydrates from cell tissue
AU561066B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Antibacterial composition containing an oligosaccharide
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
EP0089940A1 (en) * 1982-03-23 1983-09-28 BioCarp AB Compositions for therapeutic or diagnostic use containing oligosaccharides
IT1168205B (it) * 1983-07-21 1987-05-20 Wellcome Italia Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione
US4613589A (en) * 1985-08-19 1986-09-23 Abbott Laboratories D-manno-2-octulosonic acid derivatives, pharmaceutical compositions and method of use
US4613590A (en) * 1985-08-19 1986-09-23 Abbott Laboratories Amino D-manno-2-octulopyranosidonate containing compounds, pharmaceutical compositions and method of use

Also Published As

Publication number Publication date
FI86081C (fi) 1992-07-10
ES8802458A1 (es) 1988-06-16
ATE68501T1 (de) 1991-11-15
EP0179324A2 (fr) 1986-04-30
US4939123A (en) 1990-07-03
CA1280987C (en) 1991-03-05
IL76628A (en) 1991-06-10
ES557292A0 (es) 1988-06-16
NO854273L (no) 1986-04-28
DE3584414D1 (de) 1991-11-21
JPS61103829A (ja) 1986-05-22
ZA857842B (en) 1986-05-28
PT81372A (fr) 1985-11-01
CH660557A5 (fr) 1987-05-15
AU577411B2 (en) 1988-09-22
IL76628A0 (en) 1986-02-28
ES8800360A1 (es) 1987-11-01
JP2566913B2 (ja) 1996-12-25
NO164719B (no) 1990-07-30
EP0179324A3 (en) 1988-05-18
KR910008798B1 (ko) 1991-10-21
PT81372B (pt) 1987-11-30
FI854179A0 (fi) 1985-10-25
FI86081B (fi) 1992-03-31
ES548242A0 (es) 1987-11-01
AU4851485A (en) 1986-05-01
EP0179324B1 (fr) 1991-10-16
FI854179L (fi) 1986-04-27
NO164719C (no) 1990-11-07

Similar Documents

Publication Publication Date Title
KR860003269A (ko) 항균 조성물 및 그 유효성분의 제조방법
EP0310321A3 (en) Immunomodulatory azaspiranes
ATE116338T1 (de) Chemisch modifizierte proteine und deren herstellung.
KR910005892A (ko) 콜라겐 조성물 및 이의 제조방법
ATE66350T1 (de) Suessware und verfahren zur herstellung derselben.
DE59811531D1 (de) Verfahren zur Herstellung von Polyisocyanaten
ATE205056T1 (de) Teilhydrolysat aus milcheiweiss und verfahren zu dessen herstellung
PL322251A1 (en) Polymer-modified asphalt compositions of acidic reactivity and their production
ATE123227T1 (de) Kationisierte antikörper für das austragen durch die blut-gehirn-schranke.
DE3886998D1 (de) Verfahren zu Herstellung von Siliconharzpulvern.
EP0378641A4 (en) Novel antimicrobial peptide, compositions containing same and uses thereof
DE69129119D1 (en) A process for the production of polyalkylenoxide
ATE127846T1 (de) Herstellung von hv/hb copolymer.
KR840001836A (ko) 생리활성 물질의 제법
DE68905232D1 (de) Verfahren zur herstellung von thioether-funktion enthaltendem polybuten.
FR2428050A1 (fr) Oligomeres de composes du type muramyl-peptide et medicaments les contenant
IE791033L (en) Stabilised milk compositions
AU4068689A (en) Iodinated polymers with dextran skeleton, processes for their preparation and their uses as contrast products
KR880001299A (ko) 면역독소, 그의 제조방법 및 그를 함유하는 약학 조성물
GB1513185A (en) Immobilized glycoenzymes
ATE194623T1 (de) Herstellung von phosphopeptiden ausgehend von kasein
GB1436684A (en) Method for preparing glucoronyl-glucosamino-glycan sulphates exhibiting antilipaemic activity
ES8605769A1 (es) Un procedimiento para la preparacion de un peptido
EP0333399A3 (en) C-terminal alfa-amidating enzyme and process for production thereof
EP0161384A3 (en) Human endogenous cancer regulatory factors, method of preparing the same, and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19851023

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19881214

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19851023

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19910702

Patent event code: PE09021S01D

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19910925

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19920115

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19920215

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19920215

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19940728

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19950809

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 19961014

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 19970830

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 19970830

Start annual number: 7

End annual number: 7

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee